Additionally, it increases anti-inflammatory cytokines, such as IL-22, effectively inhibiting the interaction between LPS and TLR4 and reducing hepatic inflammation pathways (Jiang et al., 2023), thus providing protection against AIH. The gene discussed is TLR4; the disease is autoimmune hepatitis.